OBJECTIVE: To compare mortality rates on hemodialysis (HD) to rates on continuous ambulatory/cyclic peritoneal dialysis (CAPD/CCPD), to contrast our results with those of other recent investigations, and to discuss reasons for discrepancies. DATA SOURCES: Patient-specific data obtained from the Canadian Organ Replacement Register on patients initiating renal replacement therapy (RRT) between 1 January 1990 and 31 December 1995 (n = 14 483). Recent mortality comparisons of CAPD and HD. MAIN OUTCOME MEASURES: Mortality rate ratio (RR) based on "as-treated" (AT) analysis incorporating treatment modality switches and adjusting for age, primary renal diagnosis, and comorbid conditions using Poisson regression. Hazard ratios (HR) were estimated using Cox regression and based on an "intent-to-treat" (ITT) analysis wherein patients were classified based on dialytic modality received on follow-up day 90. RESULTS: Adjusted mortality rates were significantly decreased on CAPD/CCPD relative to HD [RR = 0.73, 95% confidence interval (CI) = (0.69, 0.77)] based on the AT analysis. Most of the protective effect of CAPD/CCPD was concentrated in the first 2 years of follow-up post-RRT initiation. Based on the ITT analysis, the estimated CAPD/ CCPD effect was greatly reduced, with HR = 0.93 (0.87, 0.99). CONCLUSIONS: We provide further evidence that CAPD/CCPD is not an inferior dialytic modality to HD, particularly in the short term. Comparing mortality rates on CAPD/CCPD and HD is inherently difficult due to the potential for bias. Discrepancies between our results and those of previous investigations, and variability in findings among previous studies, relate to differences in clinical and demographic setting, patient populations, study design, statistical methods, and interaction between the dialytic modality effect and various other covariables.

This article has been cited by other articles:

				P. M. Just, F. Th. de Charro, E. A. Tschosik, L. L. Noe, S. K. Bhattacharyya, and M. C. Riella Reimbursement and economic factors influencing dialysis modality choice around the world Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2365 - 2373. [Abstract] [Full Text] [PDF]

				E. Juergensen, D. Wuerth, S. H. Finkelstein, P. H. Juergensen, A. Bekui, and F. O. Finkelstein Hemodialysis and Peritoneal Dialysis: Patients' Assessment of Their Satisfaction with Therapy and the Impact of the Therapy on Their Lives Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1191 - 1196. [Abstract] [Full Text] [PDF]

				H. de Jonge, B. Bammens, W. Lemahieu, B. D. Maes, and Y. Vanrenterghem Comparison of peritoneal dialysis and haemodialysis after renal transplant failure Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1669 - 1674. [Abstract] [Full Text] [PDF]

				W. C. Winkelmayer, R. J. Glynn, M. A. Mittleman, R. Levin, J. S. Pliskin, and J. Avorn Comparing Mortality of Elderly Patients on Hemodialysis versus Peritoneal Dialysis: A Propensity Score Approach J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2353 - 2362. [Abstract] [Full Text] [PDF]

				S. V. Jassal, G. Krishna, N. P. Mallick, and D. C. Mendelssohn Attitudes of British Isles nephrologists towards dialysis modality selection: a questionnaire study Nephrol. Dial. Transplant., March 1, 2002; 17(3): 474 - 477. [Abstract] [Full Text] [PDF]

				J. G. Heaf, H. Lokkegaard, and M. Madsen Initial survival advantage of peritoneal dialysis relative to haemodialysis Nephrol. Dial. Transplant., January 1, 2002; 17(1): 112 - 117. [Abstract] [Full Text] [PDF]

				J. Passlick-Deetjen and E. Quellhorst Continuous flow peritoneal dialysis (CFPD): a glimpse into the future Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2296 - 2299. [Full Text] [PDF]

				D. E. SCHAUBEL and S. S. A. FENTON Trends in Mortality on Peritoneal Dialysis: Canada,1981-1997 J. Am. Soc. Nephrol., January 1, 2000; 11(1): 126 - 133. [Abstract] [Full Text]

Copyright © 1998 by Multimed Inc.